CDKN2B and central nervous system cancer: Multiple variants from one genomic region have previously been associated with cross-phenotypes e.g. the IFI30 locus in autoimmune diseases11, and the CDKN2B-ASI locus in coronary artery disease, glioma and intracranial aneurysm31.